Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcc201f4fa40dd19b8d8ef8da3e9647d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-832 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-56 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-07 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-56 |
filingDate |
1995-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1996-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c02d2cf0d0a1e364f491d8d8b54380f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_016fb8e9f37f7ef1c5e04483e1d6f95d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42919c87749fcc8fe33c0cc6b4e14df4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2947cdc723b1ef8a7c470655b772231e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be9025a55ba24af5e42c1a5a3bd1d270 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb715ed0a00d15f5a430134cec46cb9e |
publicationDate |
1996-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5494809-A |
titleOfInvention |
Method of producing iturin A and antifungal agent for profound mycosis |
abstract |
The present invention is a method of producing iturin A, in which cells of Bacillus amyloliquefaciens are incubated and iturin A is collected from the culture. It also relates to an antifungal agent for profound mycosis, containing iturin A as the active ingredient. Heretofore, there have been known few medicines effective against profound mycosis, but iturin A may be an effective antifungal agent for profound mycosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005266521-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6960342-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011140051-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004052776-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8236549-B2 |
priorityDate |
1993-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |